Trial · NCT01940900
Adverse events224
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 224
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Conjunctival haemorrhage | Eye disorders | E10030 + Ranibizumab | 74 | 312 | 166 |
| other | Conjunctival haemorrhage | Eye disorders | Sham + Ranibizumab | 50 | 314 | 136 |
| other | Punctate keratitis | Eye disorders | E10030 + Ranibizumab | 35 | 312 | 93 |
| other | Punctate keratitis | Eye disorders | Sham + Ranibizumab | 40 | 314 | 97 |
| other | Conjuctival hyperaemia | Eye disorders | E10030 + Ranibizumab | 24 | 312 | 48 |
| other | Conjuctival hyperaemia | Eye disorders | Sham + Ranibizumab | 24 | 314 | 53 |
| other | Eye pain | Eye disorders | E10030 + Ranibizumab | 22 | 312 | 51 |
| other | Eye pain | Eye disorders | Sham + Ranibizumab | 21 | 314 | 35 |
| other | Vitreous floaters | Eye disorders | E10030 + Ranibizumab | 22 | 312 | 28 |
| other | Vitreous floaters | Eye disorders | Sham + Ranibizumab | 12 | 314 | 13 |
| other | Eye irritation | Eye disorders | E10030 + Ranibizumab | 18 | 312 | 34 |
| other | Eye irritation | Eye disorders | Sham + Ranibizumab | 15 | 314 | 35 |
| other | Keratitis | Eye disorders | E10030 + Ranibizumab | 18 | 312 | 64 |
| other | Keratitis | Eye disorders | Sham + Ranibizumab | 14 | 314 | 47 |
| other | Nasopharyngitis | Infections and infestations | E10030 + Ranibizumab | 17 | 312 | 18 |
| other | Nasopharyngitis | Infections and infestations | Sham + Ranibizumab | 18 | 314 | 20 |
| other | Urinary tract infection | Infections and infestations | E10030 + Ranibizumab | 17 | 312 | 23 |
| other | Urinary tract infection | Infections and infestations | Sham + Ranibizumab | 18 | 314 | 25 |
| other | Bronchitis | Infections and infestations | E10030 + Ranibizumab | 16 | 312 | 18 |
| other | Bronchitis | Infections and infestations | Sham + Ranibizumab | 11 | 314 | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01940900/events